ClinicalTrials HQ

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Recruiting · NCT06457919 · Registry updated 2026-06-25
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderRecruitingPhase 1 / Phase 22026-06-25NCT06457919

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Memorial Sloan Kettering Cancer Center753
TransThera Sciences1

12 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Columbia UniversityNew YorkUnited States154
Duke UniversityDurhamUnited States160
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking RidgeUnited States131
Memorial Sloan Kettering Bergen (Limited Protocol Activities)MontvaleUnited States184
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)MiddletownUnited States186
Memorial Sloan Kettering Nassau (Limited Protocol Activities)UniondaleUnited States120
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)CommackUnited States55
Memorial Sloan Kettering Westchester (Limited Protocol Activities)HarrisonUnited States166
Oregon Health & Science UniversityPortlandUnited States261
Thomas Jefferson University HospitalPhiladelphiaUnited States271
Yale University (Data Collection Only)New HavenUnited States2